Azzimonti, Matteo
Preziosa, Paolo
Pagani, Elisabetta
Valsasina, Paola
Tedone, Nicolò
Vizzino, Carmen
Rocca, Maria A.
Filippi, Massimo http://orcid.org/0000-0002-5485-0479
Article History
Received: 20 March 2023
Revised: 8 May 2023
Accepted: 11 May 2023
First Online: 18 May 2023
Declarations
:
: Approval was received from the institutional ethical standards committee on human experimentation of IRCCS Ospedale San Raffaele for any experiments using human subjects (Protocol N° 2009-74). Written informed consent was obtained from all subjects prior to study participation according to the Declaration of Helsinki.
: Matteo Azzimonti has nothing to disclose. Paolo Preziosa received speaker honoraria from Roche, Biogen, Novartis, Merck Serono, Bristol Myers Squibb and Genzyme; he has received research support from the Italian Ministry of Health and Fondazione Italiana Sclerosi Multipla. Elisabetta Pagani received speaker honoraria from Biogen Idec. Paola Valsasina received speaker honoraria from Biogen Idec. Nicolò Tedone has nothing to disclose. Carmen Vizzino has nothing to disclose. Maria A. Rocca received consulting fees from Biogen, Bristol Myers Squibb, Eli Lilly, Janssen, Roche; and speaker honoraria from AstraZaneca, Biogen, Bristol Myers Squibb, Bromatech, Celgene, Genzyme, Horizon Therapeutics Italy, Merck Serono SpA, Novartis, Roche, Sanofi and Teva. She receives research support from the MS Society of Canada, the Italian Ministry of Health, and Fondazione Italiana Sclerosi Multipla. She is Associate Editor for <i>Multiple Sclerosis and Related Disorders</i>. Massimo Filippi is Editor-in-Chief of the <i>Journal of Neurology</i>, Associate Editor of <i>Human Brain Mapping</i>, <i>Neurological Sciences,</i> and <i>Radiology</i>; received compensation for consulting services from Alexion, Almirall, Biogen, Merck, Novartis, Roche, Sanofi; speaking activities from Bayer, Biogen, Celgene, Chiesi Italia SpA, Eli Lilly, Genzyme, Janssen, Merck-Serono, Neopharmed Gentili, Novartis, Novo Nordisk, Roche, Sanofi, Takeda, and TEVA; participation in Advisory Boards for Alexion, Biogen, Bristol-Myers Squibb, Merck, Novartis, Roche, Sanofi, Sanofi-Aventis, Sanofi-Genzyme, Takeda; scientific direction of educational events for Biogen, Merck, Roche, Celgene, Bristol-Myers Squibb, Lilly, Novartis, Sanofi-Genzyme; he receives research support from Biogen Idec, Merck-Serono, Novartis, Roche, Italian Ministry of Health, and Fondazione Italiana Sclerosi Multipla.